In Vivo Fluorescence Imaging of Large-Vessel Thrombosis in Mice

被引:58
作者
Cooley, Brian C. [1 ]
机构
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
基金
美国国家卫生研究院;
关键词
arterial thrombosis; blood coagulation; imaging agents; thrombosis; MOUSE MODEL; PLATELETS; INJURY; FIBRIN;
D O I
10.1161/ATVBAHA.111.225334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Experimental studies of large-vessel thrombosis have been adapted for applications in mice, but they proffer limited quantifiable information in outcome measures. This study presents a novel approach for evaluating large-vessel thrombogenesis with temporally/spatially quantifiable measures and normalization methods for interanimal comparisons. Methods and Results-Shuttered, beam-expanded lasers provided uniform narrow-wavelength illumination of a x100 microsurgical field with a large depth of focus. Thrombosis was generated in murine carotid arteries and femoral veins by brief vascular surface electrolytic injury. Thrombus-targeting fluorophores were injected systemically and subsequently localized at the site of thrombus induction. A low-light digital video camera with filter wheel provided target-specific image acquisition over a 60-minute interval. Platelets accumulated with a subsequent fibrin border emerging to stabilize the clot in both arteries and veins. Coagulation enzyme complexes colocalized with fibrin deposition. Large arteries underwent cyclic massive thromboembolization, whereas veins showed gradual shedding of microemboli and clot contraction. Systemic administration of fibrin-and platelet-inhibiting compounds reduced their respective targets but also often inhibited their clotting counterparts (platelets and fibrin, respectively) in both arteries and veins. Conclusion-Intermediate-level magnified image capture represents a novel approach for analysis of fluorescence-based in vivo imaging, with quantitative application to the study of large-vessel thrombosis. (Arterioscler Thromb Vasc Biol. 2011;31:1351-1356.)
引用
收藏
页码:1351 / U263
页数:20
相关论文
共 22 条
[1]  
[Anonymous], 1937, ACTA CHIR SCAND
[2]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[3]   A murine model of deep vein thrombosis - Characterization and validation in transgenic mice [J].
Cooley, BC ;
Szema, L ;
Chen, CY ;
Schwab, JP ;
Schmeling, G .
THROMBOSIS AND HAEMOSTASIS, 2005, 94 (03) :498-503
[4]   Murine microvascular anastomosis model of thrombosis [J].
Cooley, BC ;
Daley, RA .
THROMBOSIS RESEARCH, 1999, 96 (02) :157-159
[5]   Spontaneous thrombosis in mice carrying the factor V Leiden mutation [J].
Cui, JS ;
Eitzman, DT ;
Westrick, RJ ;
Christie, PD ;
Xu, ZJJ ;
Yang, AY ;
Purkayastha, AA ;
Yang, TL ;
Metz, AL ;
Gallagher, KP ;
Tyson, JA ;
Rosenberg, RD ;
Ginsburg, D .
BLOOD, 2000, 96 (13) :4222-4226
[6]   A mouse model of severe von Willebrand disease:: Defects in hemostasis and thrombosis [J].
Denis, C ;
Methia, N ;
Frenette, PS ;
Rayburn, H ;
Ullman-Culleré, M ;
Hynes, RO ;
Wagner, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9524-9529
[7]   Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse [J].
Falati, S ;
Gross, P ;
Merrill-Skoloff, G ;
Furie, BC ;
Furie, B .
NATURE MEDICINE, 2002, 8 (10) :1175-1180
[8]   Vitronectin inhibits the thrombotic response to arterial injury in mice [J].
Fay, WP ;
Parker, AC ;
Ansari, MN ;
Zheng, XX ;
Ginsburg, D .
BLOOD, 1999, 93 (06) :1825-1830
[9]  
FRIEDMAN M, 1966, AM J PATHOL, V48, P19
[10]   MONOCLONAL-ANTIBODIES TO A SYNTHETIC FIBRIN-LIKE PEPTIDE BIND TO HUMAN FIBRIN BUT NOT FIBRINOGEN [J].
HUI, KY ;
HABER, E ;
MATSUEDA, GR .
SCIENCE, 1983, 222 (4628) :1129-1132